SCHEMBL4024315

SCHEMBL4024315

NS(=O)(=O)c1ccc2c(c1)S(=O)(=O)N=NC2

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 15/20 0.53
CA2 P00918 15/20 0.53
CA9 Q16790 11/20 0.53
CA12 O43570 8/20 0.44
CA7 P43166 5/20 0.44
CA14 Q9ULX7 4/20 0.44
ALOX5 P09917 2/20 0.43
GLO1 Q04760 1/20 0.41
ADRA2A P08913 1/20 0.39
PNMT P11086 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
LMNA P02545 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA5B Q9Y2D0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8024515 0.69 CA2 (1.00) CA1CA2CA9CA12CA7
SCHEMBL5288239 0.67 CA1 (0.45) CA1CA2CA9CA12CA7
SCHEMBL17824795 0.67 CA1 (0.45) CA1CA2CA9CA12CA7
SCHEMBL9810165 0.67 CA1 (0.46) CA1CA2CA9CA12CA7
SCHEMBL6297784 0.67 CA2 (0.82) CA1CA2CA9CA12CA7
SCHEMBL17350895 0.66 CA1 (0.57) CA1CA2CA9CA12CA7
SCHEMBL29902411 0.63 MEN1 (0.63) CA1CA2CA9CA12CA7
SCHEMBL27546526 0.62 CA1 (0.60) CA1CA2CA9CA12CA7
SCHEMBL17350894 0.62 CA1 (0.48) CA1CA2CA9CA12CA7
SCHEMBL8029327 0.62 CA2 (0.76) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968439-A2 COMPOSITIONS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS Synergy Pharmaceuticals Inc. (US) 2016-01-20 EP disclosed
WO-2014151200-A2 COMPOSITIONS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS SYNERGY PHARMACEUTICALS INC. (US) 2014-09-25 WO disclosed
WO-2009091813-A1 COMPOUNDS USEFUL AS ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS WYETH (US) 2009-07-23 WO disclosed